Cargando…

Increase in the Length of Lung Cancer Patient Pathway Before First-Line Therapy: A 6-Year Nationwide Analysis From Hungary

Objective: This study aimed to examine the characteristics of the lung cancer (LC) patient pathway in Hungary during a 6-years period. Methods: This nationwide, retrospective study included patients newly diagnosed with LC (ICD-10 C34) between January 1, 2011, and December 31, 2016, using data from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kiss, Zoltan, Bogos, Krisztina, Tamási, Lilla, Ostoros, Gyula, Müller, Veronika, Urbán, László, Bittner, Nóra, Sárosi, Veronika, Vastag, Aladár, Polányi, Zoltán, Nagy-Erdei, Zsófia, Knollmajer, Kata, Várnai, Máté, Nagy, Balázs, Horváth, Krisztián, Rokszin, György, Abonyi-Tóth, Zsolt, Barcza, Zsófia, Moldvay, Judit, Gálffy, Gabriella, Vokó, Zoltán
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pathology and Oncology Archive
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734146/ https://www.ncbi.nlm.nih.gov/pubmed/35002544 http://dx.doi.org/10.3389/pore.2021.1610041

Ejemplares similares

Significant Regional Differences in Lung Cancer Incidence in Hungary: Epidemiological Study Between 2011 and 2016
por: Gálffy, Gabriella, et al.
Publicado: (2021)

Revising Incidence and Mortality of Lung Cancer in Central Europe: An Epidemiology Review From Hungary
por: Bogos, Krisztina, et al.
Publicado: (2019)

Age and Gender Specific Lung Cancer Incidence and Mortality in Hungary: Trends from 2011 Through 2016
por: Tamási, Lilla, et al.
Publicado: (2021)

Improvement in Lung Cancer Survival: 6-Year Trends of Overall Survival at Hungarian Patients Diagnosed in 2011–2016
por: Bogos, Krisztina, et al.
Publicado: (2021)

Underlying reasons for post-mortem diagnosed lung cancer cases – A robust retrospective comparative study from Hungary (HULC study)
por: Kiss, Zolta´n, et al.
Publicado: (2022)

Significant changes in advanced lung cancer survival during the past decade in Hungary: impact of modern immunotherapy and the COVID-19 pandemic
por: Kiss, Zoltán, et al.
Publicado: (2023)

Changing Trends in Melanoma Incidence and Decreasing Melanoma Mortality in Hungary Between 2011 and 2019: A Nationwide Epidemiological Study
por: Liszkay, Gabriella, et al.
Publicado: (2021)

Improving Quality Indicator of Melanoma Management – Change of Melanoma Mortality-to-Incidence Rate Ratio Based on a Hungarian Nationwide Retrospective Study
por: Várnai, Máté, et al.
Publicado: (2021)

Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study)
por: Vokó, Zoltán, et al.
Publicado: (2022)

Opposite trends in incidence of breast cancer in young and old female cohorts in Hungary and the impact of the Covid-19 pandemic: a nationwide study between 2011–2020
por: Kiss, Zoltán, et al.
Publicado: (2023)

Nationwide Effectiveness of First and Second SARS-CoV2 Booster Vaccines During the Delta and Omicron Pandemic Waves in Hungary (HUN-VE 2 Study)
por: Kiss, Zoltán, et al.
Publicado: (2022)

Different Trends in Excess Mortality in a Central European Country Compared to Main European Regions in the Year of the COVID-19 Pandemic (2020): a Hungarian Analysis
por: Bogos, Krisztina, et al.
Publicado: (2021)

Persistence with statin therapy in Hungary
por: Kiss, Zoltan, et al.
Publicado: (2013)

A survey of the burden of allergic rhinitis in Hungary from a specialist’s perspective
por: Szilasi, Mária, et al.
Publicado: (2012)

Lung cancer drug therapy in Hungary – 3-year experience
por: Moldvay, Judit, et al.
Publicado: (2015)

Nationwide effectiveness of five SARS-CoV-2 vaccines in Hungary—the HUN-VE study
por: Vokó, Zoltán, et al.
Publicado: (2022)

General practitioners can increase participation in cervical cancer screening – a model program in Hungary
por: Gyulai, Anikó, et al.
Publicado: (2018)

Different Changes of Risks for Stroke and Myocardial Infarction in Patients With Type 2 Diabetes in Hungary Between the Two Periods of 2001–2004 and 2010–2013
por: Kiss, Zoltan, et al.
Publicado: (2019)

Dissimilar impact of type 2 diabetes on cardiovascular outcomes according to age categories: a nationwide population study from Hungary
por: Kiss, Zoltán, et al.
Publicado: (2018)

Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer screening in Hungary
por: Vokó, Zoltán, et al.
Publicado: (2012)

Changing Patterns of Antihyperglycaemic Treatment among Patients with Type 2 Diabetes in Hungary between 2015 and 2020—Nationwide Data from a Register-Based Analysis
por: Jermendy, György, et al.
Publicado: (2022)

Changes in the incidence and prevalence of type 1 and type 2 diabetes among 2 million children and adolescents in Hungary between 2001 and 2016 – a nationwide population-based study
por: Barkai, László, et al.
Publicado: (2019)

Investigation of circulating lncRNAs as potential biomarkers in chronic respiratory diseases
por: Gál, Zsófia, et al.
Publicado: (2020)

Pitfalls associated with the therapeutic reference pricing practice of asthma medication
por: Kalo, Zoltan, et al.
Publicado: (2012)

Impact of Clinical Factors on Generic and Disease-Specific Quality of Life in COPD and Asthma-COPD Overlap with Exacerbations
por: Lázár, Zsófia, et al.
Publicado: (2020)

Substantial variation across geographic regions in the obesity prevalence among 6–8 years old Hungarian children (COSI Hungary 2016)
por: Erdei, Gergő, et al.
Publicado: (2018)

Author Correction: Plasma neutrophil extracellular trap level is modified by disease severity and inhaled corticosteroids in chronic inflammatory lung diseases
por: Gál, Zsófia, et al.
Publicado: (2020)

Plasma neutrophil extracellular trap level is modified by disease severity and inhaled corticosteroids in chronic inflammatory lung diseases
por: Gál, Zsófia, et al.
Publicado: (2020)

Different patterns of excess all-cause mortality by age and sex in Hungary during the 2(nd) and 3(rd) waves of the COVID-19 pandemic
por: Fazekas-Pongor, Vince, et al.
Publicado: (2022)

Effects of adult growth hormone deficiency and replacement therapy on the cardiometabolic risk profile
por: Ratku, Balázs, et al.
Publicado: (2022)

Single‐center study of autoimmune encephalitis‐related autoantibody testing in Hungary
por: Hayden, Zsófia, et al.
Publicado: (2019)

Investigation of the Possible Role of the Hippo/YAP1 Pathway in Asthma and Allergy
por: Fodor, Lili E., et al.
Publicado: (2017)

Incremental cost of premature birth – a public health care payer perspective from Hungary
por: Kovács, Gábor, et al.
Publicado: (2023)

Consumer acceptance of genetic-based personalized nutrition in Hungary
por: Szakály, Zoltán, et al.
Publicado: (2021)

Corrigendum: Investigation of the Possible Role of Tie2 Pathway and TEK Gene in Asthma and Allergic Conjunctivitis
por: Gál, Zsófia, et al.
Publicado: (2020)

Investigation of the Possible Role of Tie2 Pathway and TEK Gene in Asthma and Allergic Conjunctivitis
por: Gál, Zsófia, et al.
Publicado: (2020)

Human cases of lymphocytic choriomeningitis virus (LCMV) infections in Hungary
por: Pankovics, Péter, et al.
Publicado: (2023)

Inhaler Competence and Patient Satisfaction with Easyhaler(®): Results of Two Real-Life Multicentre Studies in Asthma and COPD
por: Gálffy, Gabriella, et al.
Publicado: (2013)

Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data
por: Müller, Veronika, et al.
Publicado: (2016)

Two-Year Follow-Up after Contact Force Sensing Radiofrequency Catheter and Second-Generation Cryoballoon Ablation for Paroxysmal Atrial Fibrillation: A Comparative Single Centre Study
por: Kardos, Attila, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pkbd0r8i6f1rhe4qb7qr8ir5np